期刊文献+

3-乙酰基-2,3/2,5-二氢-1,5-苯并硫氮杂卓的选择性合成及其互变异构 被引量:5

Selective Synthesis and Tautomerism of 3-Acetyl-2,3/2,5-dihydro-1,5-benzothiazepines
原文传递
导出
摘要 研究了温度、时间等因素对合成反应的影响,发现亚胺型杂卓4和烯胺型杂卓5分别为速度控制产物和平衡控制产物,并且实现了两种互变异构体的选择性合成.用核磁共振法研究了溶剂、酸碱度对4,5互变异构的影响,发现两种异构体在CD3OD,DMSO-d6,C6D6以及精制的CDCl3中比较稳定,在未精制的CDCl3中容易发生互变及开环反应,形成3,4,5的平衡混合物,并以4为主要组分.4,5在酸中不稳定,但在弱碱(吡啶)中能稳定存在.采用密度泛函理论方法在B3LYP/6-31G基组水平上对四组(八种)不同取代基的上述异构体进行了几何优化和计算.结果表明,烯胺型杂卓5比亚胺型杂卓4稳定,理论计算结果与实验结果基本一致. The selective synthesis of 2,3/2,5-dihydro-1,5-benzothiazepines was achieved by controlled re-action conditions.Detailed studies on reaction temperature,reaction time revealed that 2,3-dihydro-1,5-benzothiazepines(imine tautomers)(4) and 2,5-dihydro-1,5-benzothiazepines(enamine tautomers)(5) are speed-controlled and balance-controlled products,respectively.The imine-enamine tautomerism of 4 and 5 in different solvents was investigated by means of NMR spectroscopy.The result showed that 4 or 5 are al-most stable in DMSO-d6,C6D6,CD3OD and purified CDCl3.When 4 or 5 were disolved in unpurified CDCl3,the equilibria were established between 4,5 and 3 with the imine tautomers 4 as the major species.The interconversion of compounds 4,5 and 3 was also observed in acidic solution of C6D6,but not in basic solution of the same solvent.The stability of 2,3/2,5-dihydro-1,5-benzothiazepine tautomers was studied by density functional theory at B3LYP/6-31G level.The theoretical results showed that enamine tautomers 5 are more stable than imine tautomers 4 which are consistent with the experimental results.
出处 《化学学报》 SCIE CAS CSCD 北大核心 2011年第10期1217-1224,共8页 Acta Chimica Sinica
基金 国家自然科学基金(No.20972040) 河北省自然科学基金(No.B2009000255)资助项目
关键词 1 5-苯并硫氮杂卓 速度控制产物 平衡控制产物 亚胺 烯胺 互变异构 1 5-benzothiazepine speed-controlled product balance-controlled product imine enamine tautomerism
  • 相关文献

参考文献16

  • 1Skiles, J. W.; Sorcek, R.; Jacober, S.; Miao, C.; Mui, P. W.; Mcneil, D.; Rosenthal, A. S. Bioorg. Med. Chem. Lett. 1993, 3, 773.
  • 2Slade, J.; Stanton, J.; Ben-David, J. D.; Mazzenga, G. C. J. Med. Chem. 1985, 28, 7.
  • 3Nagao, T.; Sato, M.; Iwasawa, Y.; Takada, T.; Ishida, R. Jpn. J. Pharmacol. 1972, 22, 467.
  • 4Nagao, T.; Sato, M.; Nakajima, H.; Kiyomoto, A. Chem. Pharm. Bull. 1973, 21, 92.
  • 5Yamada, K.; Shimamura, T.; Nakajima, H. Jpn. J. Phar- macol. 1973, 23, 321.
  • 6Yamamoto, H.; Asai, H. Chem. Pharm. Bull. 1986, 34, 3844.
  • 7Asano, T.; Okumura, T.; Hirano, K.; Adachi, T.; Sugiura, M. Chem. Pharm. Bull. 1986, 34, 4238.
  • 8Ambrogi, V.; Furlani, A.; Grandolini, G.; Papaioannou, A.; Perioli, L.; Scarcia, V.; Tuttobello, L. Eur. J. Med. Chem. 1993, 28, 659.
  • 9Desai, M. D.; Desai, K. K. Asian J. Chem. 2002, 14, 974.
  • 10李文红 兰佳明 李成 曹云涛 王海波 王兰芝 张萍 王永祥 李媛.化学学报,2009,67:2732-2732.

共引文献1

同被引文献73

  • 1李宝宗.可乐定分子构象异构和互变异构的理论研究[J].化学学报,2006,64(4):278-282. 被引量:16
  • 2刘国发,滕永富,师同顺.固相反应合成卟啉类配合物[J].高等学校化学学报,1996,17(7):1022-1024. 被引量:5
  • 3傅献彩 陈瑞华.物理化学[M].北京:人民教育出版社,1979..
  • 4Atwal KS, Bergey JL, Hedberg A, Moreland S. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4- methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters. J Med Chem, 1987, 30(4): 635-640.
  • 5Tarabova B, Lacinova L, Engel J. Effects of phenylalkylamines and benzothiazepines on Cav1.3-mediated Ca2+ currents in neonatal mouse inner hair cells. Eur J Pharmacol, 2007, 573(1): 39-48.
  • 6Inoue H, Konda M, Hashiyama T, Otsuka H, Takahashi K, Gaino M, Date T, Aoe K, Takeda M, Murata S, Narita H, Nagao T. Synthesis of halogen-substituted 1,5-benzothiazepine derivatives and their vasodilating and hypotensive activities. J Med Chem, 1991, 34: 675-687.
  • 7Yamamoto H, Asai H. Effects of (-)-cis-2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1, 5-benzothiazepin-4-(5H)-one hydrochl- oride (BTM-I086) on ulceration, gastric secretion and mucosal blood flow in experimental animals. Chem Pharm Bull, 1986, 34: 3844-3853.
  • 8Asano T, Okumura T, Hirano K, Adachi T, Sugiura M. Competitive enzyme immunoassay for anti-ulcer agent, (-)-cis-2,3-dihydro-3- (4-methylpiperazinylmethyl)-2-phenyl-l,5- benzothiazepin-4(5H)-one hydrochloride (BTM-I086). Chem Pharm Bull, 1986, 34: 4238-4243.
  • 9Ambrogi V, Furlani A, Grandolini G, Papaioannou A, Perioli L, Scarcia V, Tuttobello L. Synthesis, antimicrobial and cytostatic activities of some derivatives of indolo[2,3-b]-1,5-benzothiazepine, a novel heterocyclic ring system. Eur J Med Chem, 1993, 28: 659-667.
  • 10Desai MD, Desai KK. Synthesis and antibacterial activity of 1,5-benzothiazepine derivatives. Asian J Chem, 2002, 14(2): 974-978.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部